Skip to content
Screener

McKesson MCK Medical-Surgical Solutions — Payments for Restructuring

Other segment segments

North American Pharmaceutical
$3M
Oncology & Multispecialty
$0
Prescription Technology Solutions
$0

Similar metrics at other companies

Matthews International logo
MATWBrand Solutions — Payments for Restructuring
$0-100%
PSK
PSKYTV Media — Payments for Restructuring
$113M
DENTSPLY SIRONA logo
XRAYConnected Technology Solutions — Payments for Restructuring
$2M0.0%
DENTSPLY SIRONA logo
XRAYEssential Dental Solutions — Payments for Restructuring
$7M+133%
Kaltura, Inc. logo
KLTRMedia and Telecom — Payments for Restructuring
$31K-66.8%
DENTSPLY SIRONA logo
XRAYOrthodontic and Implant Solutions — Payments for Restructuring
$3M+50.0%

Other financials

Income statement

See full
Revenue$105.38B+7.7%
Gross profit$3.7B+12.4%
Operating income$1.3B+27.3%
Net income$614.0M-21.7%
EPS (diluted)$5.15-17.6%

Balance sheet

See full
Cash & equivalents$5.3B+95.9%
Total debt$13.0B+15.7%
Total equity-$4.2B-116%
Total assets$88.3B+8.6%

Cash flow

See full
Operating cash flow-$220.0M+76.0%
CapEx$112.0M+0.9%
Free cash flow-$332.0M+67.7%

Valuation

See full
Market cap$101.59B+15.6%
Enterprise value$109.31B+13.4%
P/E22.1×-5.7×
P/S0.3×0.0×

Profitability

See full
Gross margin3.6%+0.1pp
Operating margin1.6%+0.4pp
Net margin1.1%+0.3pp
FCF margin1.6%0.0pp

Returns & leverage

See full
Return on equity36%
Debt / equity
Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRestructuring.

The source filing: McKesson’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:29 PM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0000927653-26-000234
(In millions)North American PharmaceuticalPrescription Technology SolutionsMedical-Surgical SolutionsCorporateTotal
Balance, March 31, 2026 (1)$18$3$10$13$44
Restructuring, impairment, and related charges, net2612350136
Non-cash charges(1)(40)(6)(47)
Cash payments(3)(16)(40)(59)
Balance, June 30, 2026 (2)$16$24$17$17$74

Item 1. Condensed Consolidated Financial Statements.

FAQ

What is McKesson's medical-surgical solutions — payments for restructuring?
McKesson (MCK) reported medical-surgical solutions — payments for restructuring of $16M in Q2 2026.
How has McKesson's medical-surgical solutions — payments for restructuring changed year-over-year?
McKesson's medical-surgical solutions — payments for restructuring decreased by 68.0% year-over-year, from $50M to $16M.
What is the long-term trend for McKesson's medical-surgical solutions — payments for restructuring?
Over 4 years (2022 to 2026), McKesson's medical-surgical solutions — payments for restructuring has grown at a 117.0% compound annual growth rate (CAGR), from $6M to $133M.
What does medical-surgical solutions — payments for restructuring mean?
This metric tracks the actual cash outflows made to settle liabilities related to restructuring activities within the Medical-Surgical Solutions segment. It provides a view of the cash impact of previously announced transformation or reorganization plans.

Ask your AI about McKesson's medical-surgical solutions — payments for restructuring.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude